Search Within

Mark Andrew Dickson

  1. "Sarcoma Surgeons"
Formats
  1. Journal Article (31)
  2. Meeting Abstract (24)
Groups
  1. Department of Medicine (55)
  2. Sarcoma Service (55)
  3. Sarcoma Surgeons (55)
  4. Solid Tumor Oncology Division (55)
  5. Surgery (55)
  6. GSK Faculty (54)

More Groups

People
  1. Samuel Singer (51)
  2. William Tap (49)
  3. Mary Keohan (41)
  4. Sandra D'Angelo (40)
  5. Mrinal Gounder (39)
  6. Cristina Antonescu (38)

More People

Years
  1. 2024 (6)
  2. 2023 (4)
  3. 2022 (11)
  4. 2021 (3)
  5. 2020 (4)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (18)
  2. Clinical Cancer Research (9)
  3. Annals of Oncology (5)
  4. Nature Communications (4)
  5. JAMA Oncology (2)
  6. Modern Pathology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. American Association for Cancer Research (10)
  3. Oxford University Press (7)
  4. Nature Publishing Group (6)
  5. American Medical Association (2)
  6. Elsevier Inc. (2)

More Publishers

Results (55)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas
    Meeting Abstract

    Rosenbaum, E.; Ehrich, F.; Bradic, M.; Kelly, C. M.; Movva, S.; Chan, J.; Chi, P.; Banks, L.; Dickson, M.; Keohan, M. L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Kelly, C. M.; Bradic, M.; Saunds, S.; Avutu, V.; Chan, J.; D'Angelo, S. P.; Dickson, M.; Gounder, M.; Keohan, M. L.; Movva, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M.; Movva, S.; Kelly, C. M.; Chan, J.; Chi, P.; Banks, L.; Keohan, M. L.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Do patients with myxofibrosarcoma and undifferentiated pleomorphic sarcoma have different clinical outcomes to immune checkpoint blockade-based therapy?
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Bradic, M.; Desir, R.; Kelly, C. M.; Movva, S.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • GLI1 coamplification in well-differentiated/dedifferentiated liposarcomas: Clinicopathologic and molecular analysis of 92 cases
    Journal Article

    Sharma, A. E.; Dickson, M.; Singer, S.; Hameed, M. R.; Agaram, N. P.
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-Mérida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte Mérida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Expanding the molecular diversity of CIC-rearranged sarcomas with novel and very rare partners
    Journal Article

    Linos, K.; Dermawan, J. K.; Bale, T.; Rosenblum, M. K.; Singer, S.; Tap, W.; Dickson, M. A.; Hornick, J. L.; Antonescu, C. R.
    Modern Pathology (2023)

    Fulltext@MSK | Save